3 ms·
>Several who tried to start companies to develop Alzheimer’s cures were told again and again by venture capital firms and major biopharma companies that they wo
by LatteLazy 7y ago
>Several who tried to start companies to develop Alzheimer’s cures were told again and again by venture capital firms and major biopharma companies that they would back only an amyloid approach.
I wonder if that's because their internal advice was from "cabal members" or if they didn't like the fundamental science or some other reason? Maybe the economics of (well understood) beta amyloid ideas worked better economically than new ideas (I guess it's a big, unhedgable gamble to invest in something that might be a cure, but won't be on the market for 20 years).
The whole point of venture capital is to fund things that "mainstream" has rejected but rejected without good reason. That does make me wonder a bit how good the science behind other ideas was.